.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for incorporation of people with MASLD as well as size of liver results in cardio-- renal-- metabolic tests, when data advise mechanistically conceivable perks as well as professional protection-- as well as outlines factors to consider for trial style as well as governing approval.